AI News

    AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

    Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

    Read the full story at Wired AI

    Get the day's AI news in one short email. Free.

    WA

    Wired AI

    Source

    Wired AI
    AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
    AI Analysis

    Generated insight by OnAirToday AI

    AI is accelerating drug discovery and development, potentially bringing novel treatments to patients faster than traditional methods. This marks a significant step towards realizing the transformative power of artificial intelligence in healthcare.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at Wired AI →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000

    Subscribe to our Free AI Newsletter

    The Daily AI Digest, every morning. Pick your topics after you subscribe.

    Free. Unsubscribe anytime.